Future Topics in Development:

Papers will soon be available demonstrating value in a variety of areas including Rare Diseases, Pain and more. Stay tuned!

Pfizer has long maintained that medicines provide tremendous value to individuals and society as a whole. We have now captured that value in a series of concise, easy-to-access papers that detail the societal and economic value provided by medicines that treat various disease areas. The data we provide come from published, peer-reviewed studies and are complemented by real stories from patients who have benefited from medicines. We hope these will serve as a resource to those looking to quantify the value of medicines.

Supporting videos:

Pfizer's "Value of Medicines" papers outline the social health and economic value of a variety of classes of treatments. The supporting 90-second videos below illustrate the positive impact that medicines have had on two patients, Matt Woods and Jack Whelan. Both faced life-threatening health conditions. Their stories provide insights into the important role that medicines have played in their respective journeys towards improved health.

Select Infographics from these papers:

From Value of Oncology Medicines: 5-Year Relative Survival Rates for Cancers in US2

From Value of Drug Adherence: Return on Investment from Improved Medication Adherence: Diabetes3

History of Development: Targeted Treatment Options for Advanced RCC

Thirty-three percent of all smoking-related deaths are from cardiovascular diseases